273 related articles for article (PubMed ID: 29512177)
1. Patterns and profiles of methylphenidate use both in children and adults.
Pauly V; Frauger E; Lepelley M; Mallaret M; Boucherie Q; Micallef J
Br J Clin Pharmacol; 2018 Jun; 84(6):1215-1227. PubMed ID: 29512177
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate: Gender trends in adult and pediatric populations over a 7year period.
Ehrhardt C; Boucherie Q; Pauly V; Braunstein D; Ronflé E; Thirion X; Frauger E; Micallef J
Therapie; 2017 Dec; 72(6):635-641. PubMed ID: 29061293
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and patterns of methylphenidate use in French children and adolescents.
Knellwolf AL; Deligne J; Chiarotti F; Auleley GR; Palmieri S; Boisgard CB; Panei P; Autret-Leca E
Eur J Clin Pharmacol; 2008 Mar; 64(3):311-7. PubMed ID: 18026941
[TBL] [Abstract][Full Text] [Related]
4. Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.
Garbe E; Mikolajczyk RT; Banaschewski T; Petermann U; Petermann F; Kraut AA; Langner I
J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):452-8. PubMed ID: 23234588
[TBL] [Abstract][Full Text] [Related]
5. ADHD Medication Trends in Turkey: 2009-2013.
Öner Ö; Yilmaz EŞ; Karadağ H; Vural M; Vural EH; Akbulat A; Gürsöz H; Türkçapar H; Kerman S
J Atten Disord; 2017 Dec; 21(14):1192-1197. PubMed ID: 24554298
[TBL] [Abstract][Full Text] [Related]
6. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.
Pottegård A; Bjerregaard BK; Glintborg D; Kortegaard LS; Hallas J; Moreno SI
Eur J Clin Pharmacol; 2013 Mar; 69(3):589-98. PubMed ID: 22811260
[TBL] [Abstract][Full Text] [Related]
7. Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005 to 2008.
Frauger E; Pauly V; Natali F; Pradel V; Reggio P; Coudert H; Thirion X; Micallef J
CNS Drugs; 2011 May; 25(5):415-24. PubMed ID: 21476612
[TBL] [Abstract][Full Text] [Related]
8. Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.
Štuhec M; Locatelli I; Švab V
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):254-9. PubMed ID: 25803789
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities in ADHD children treated with methylphenidate: a database study.
Kraut AA; Langner I; Lindemann C; Banaschewski T; Petermann U; Petermann F; Mikolajczyk RT; Garbe E
BMC Psychiatry; 2013 Jan; 13():11. PubMed ID: 23294623
[TBL] [Abstract][Full Text] [Related]
10. Changing Epidemiology of Methylphenidate Prescriptions in the Community: A Multifactorial Model.
Jaber L; Rigler S; Shuper A; Diamond G
J Atten Disord; 2017 Dec; 21(14):1143-1150. PubMed ID: 24776713
[TBL] [Abstract][Full Text] [Related]
11. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.
Raman SR; Man KKC; Bahmanyar S; Berard A; Bilder S; Boukhris T; Bushnell G; Crystal S; Furu K; KaoYang YH; Karlstad Ø; Kieler H; Kubota K; Lai EC; Martikainen JE; Maura G; Moore N; Montero D; Nakamura H; Neumann A; Pate V; Pottegård A; Pratt NL; Roughead EE; Macias Saint-Gerons D; Stürmer T; Su CC; Zoega H; Sturkenbroom MCJM; Chan EW; Coghill D; Ip P; Wong ICK
Lancet Psychiatry; 2018 Oct; 5(10):824-835. PubMed ID: 30220514
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of cases with methylphenidate abuse, dependence or withdrawal: an analysis of spontaneous reports in EudraVigilance.
Hartmayer LT; Hoffmann F; Bachmann CJ; Jobski K
Int Clin Psychopharmacol; 2023 May; 38(3):169-178. PubMed ID: 36728576
[TBL] [Abstract][Full Text] [Related]
13. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
[TBL] [Abstract][Full Text] [Related]
14. Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder.
Olfson M; Marcus SC; Zhang HF; Wan GJ
J Manag Care Pharm; 2007 Sep; 13(7):570-7. PubMed ID: 17874863
[TBL] [Abstract][Full Text] [Related]
15. Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan.
Wang LJ; Yang KC; Lee SY; Yang CJ; Huang TS; Lee TL; Yuan SS; Shyu YC
PLoS One; 2016; 11(8):e0161061. PubMed ID: 27518196
[TBL] [Abstract][Full Text] [Related]
16. Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder.
Scholle O; Banaschewski T; Enders D; Garbe E; Riedel O
J Child Adolesc Psychopharmacol; 2018; 28(6):415-422. PubMed ID: 29768038
[TBL] [Abstract][Full Text] [Related]
17. Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine.
Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Wang LJ
Clin Ther; 2016 Mar; 38(3):595-602. PubMed ID: 26874787
[TBL] [Abstract][Full Text] [Related]
18. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
Simon N; Rolland B; Karila L
Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
[TBL] [Abstract][Full Text] [Related]
19. Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users.
Darredeau C; Barrett SP; Jardin B; Pihl RO
Hum Psychopharmacol; 2007 Dec; 22(8):529-36. PubMed ID: 17910020
[TBL] [Abstract][Full Text] [Related]
20. Prescription of methylphenidate to children and youth, 1990-1996.
Miller AR; Lalonde CE; McGrail KM; Armstrong RW
CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
